SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001410578-19-001554
Filing Date
2019-10-07
Accepted
2019-10-07 07:30:38
Documents
14
Period of Report
2019-10-07
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tv530720_8k.htm   iXBRL 8-K 24582
2 EXHIBIT 99.1 tv530720_ex99-1.htm EX-99.1 7435
3 GRAPHIC tv530720_ex99-1img01.jpg GRAPHIC 16156
  Complete submission text file 0001410578-19-001554.txt   231257

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA egrx-20191007.xsd EX-101.SCH 3183
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE egrx-20191007_lab.xml EX-101.LAB 34591
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE egrx-20191007_pre.xml EX-101.PRE 22708
10 EXTRACTED XBRL INSTANCE DOCUMENT tv530720_8k_htm.xml XML 3618
Mailing Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677
Business Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677 201-326-5300
EAGLE PHARMACEUTICALS, INC. (Filer) CIK: 0000827871 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36306 | Film No.: 191139636
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences